Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200

BACKGROUND AND OBJECTIVE

Immune escape by tumors can occur by multiple mechanisms, each a significant barrier to immunotherapy. We previously demonstrated that upregulation of the immunosuppressive molecule CD200 on chronic lymphocytic leukemia cells inhibits Th1 cytokine production required for an effective cytotoxic T cell response. CD200 expression on human tumor cells in animal models prevents human lymphocytes from rejecting the tumor; treatment with an antagonistic anti-CD200 antibody restored lymphocyte-mediated tumor growth inhibition. The current study evaluated CD200 expression on solid cancers, and its effect on immune response in vitro.

METHODS AND RESULTS

CD200 protein was expressed on the surface of 5/8 ovarian cancer, 2/4 melanoma, 2/2 neuroblastoma and 2/3 renal carcinoma cell lines tested, but CD200 was absent on prostate, lung, breast, astrocytoma, or glioblastoma cell lines. Evaluation of patient samples by immunohistochemistry showed strong, membrane-associated CD200 staining on malignant cells of melanoma (4/4), ovarian cancer (3/3) and clear cell renal cell carcinoma (ccRCC) (2/3), but also on normal ovary and kidney. CD200 expression on melanoma metastases was determined by RT-QPCR, and was found to be significantly higher in jejunum metastases (2/2) and lung metastases (2/6) than in normal samples. Addition of CD200-expressing, but not CD200-negative solid tumor cell lines to mixed lymphocyte reactions downregulated the production of Th1 cytokines. Inclusion of antagonistic anti-CD200 antibody restored Th1 cytokine responses.

CONCLUSION

These data suggest that melanoma, ccRCC and ovarian tumor cells can express CD200, thereby potentially suppressing anti-tumor immune responses. CD200 blockade with an antagonistic antibody may permit an effective anti-tumor immune response in these solid tumor types.

Effects of dietary fiber and reduced crude protein on ammonia emission from laying-hen manure

Ammonia (NH(3)) emission is a major concern for the poultry industry. The objective of this research was to determine whether inclusion of dietary fiber and a reduced dietary CP content would decrease NH(3) emission from laying-hen manure. A total of 256 Hy-Line W-36 hens were fed diets with 2 levels of CP (normal and reduced) and 4 fiber treatments in a 2 x 4 factorial arrangement. The fiber treatments included a corn and soybean meal-based control diet and diets formulated with either 10.0% corn dried distillers grains with solubles (DDGS), 7.3% wheat middlings (WM), or 4.8% soybean hulls (SH) to contribute equal amounts of additional neutral detergent fiber. The CP contents of the reduced-CP diets were approximately 1 percentage unit lower than those of the normal-CP diets. All diets were formulated on the basis of digestible amino acid content and were formulated to be isoenergetic. Fresh manure was collected such that pH, uric acid, and Kjeldahl N contents could be measured. The NH(3) emission from manure was measured over 7 d by placing pooled 24-h manure samples in NH(3) emission vessels. Data were analyzed by ANOVA with Dunnett's multiple-comparisons procedure to compare results from the fiber treatments with the control, whereas the main effect of protein was used to compare the normal- and reduced-CP treatments. Dietary corn DDGS, WM, or SH lowered (P <or= 0.01) the 7-d cumulative manure NH(3) emission from 3.9 g/kg of DM manure for the control to 1.9, 2.1, and 2.3 g/kg of DM manure, respectively, and lowered (P < 0.05) the daily NH(3) emission rate. Results of this study showed that dietary inclusion of 10.0% corn DDGS, 7.3% WM, or 4.8% SH lowered NH(3) emission from laying-hen manure; however, reducing the CP content by 1 percentage unit had no measurable effect on NH(3) emission.

Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells

Most advanced solid tumors metastasize to different organs. However, no gene therapy effective for multiple tumors has yet been developed. Since a unique characteristic of bone marrow-derived mesenchymal stem cells (MSCs) is that they migrate to tumor tissues, we wanted to determine whether MSCs could serve as a vehicle of gene therapy for targeting multiple tumors. First, we confirmed that mouse MSCs preferentially migrate to multiple tumors of the lung in the Colon-26 (C-26) lung metastasis model. Next, MSCs were efficiently transduced with NK4, an antagonist of hepatocyte growth factor (HGF), by an adenoviral vector with an RGD motif. MSCs expressing NK4 (NK4-MSCs) strongly inhibited development of lung metastases in the C-26 lung metastasis model after systemic administration via a tail vein. Treatment with NK4-MSCs significantly prolonged survival of the C-26-tumor-bearing mice by inhibiting tumor-associated angiogenesis and lymphangiogenesis and inducing apoptosis of the tumor cells. MSC-based gene therapy did not induce the severe adverse effects induced by conventional adenoviral vectors. These results indicate that MSCs can serve as a vehicle of gene therapy for targeting multiple lung metastatic tumors.

Effects of Dietary Fiber and Reduced Crude Protein on Nitrogen Balance and Egg Production in Laying Hens

Ammonia emission is a major concern for the poultry industry and can be lowered by dietary inclusion of fibrous ingredients and by lowering the dietary CP content. The objectives of this research were to determine the effects of dietary fiber and reduced-CP diets, which may lower NH(3) emission, on egg production and N balance in laying hens. A total of 256 Hy-Line W-36 hens were fed diets with 2 contents of CP (normal and reduced) and 4 fiber treatments in a 2 x 4 factorial arrangement from 23 to 58 wk of age. The fiber treatments included a corn and soybean meal-based control diet and diets formulated with either 10.0% corn dried distillers grains with solubles (DDGS), 7.3% wheat middlings (WM), or 4.8% soybean hulls (SH) added to contribute equal amounts of neutral detergent fiber. The CP contents of the reduced-CP diets were approximately 1 percentage unit lower than that of the normal-CP diets. All diets were formulated on a digestible amino acid basis to be isoenergetic. There were no effects (P > 0.05) of including corn DDGS, WM, or SH in the diet on egg production, egg weight, egg mass, yolk color, feed consumption, feed utilization, or BW gain. Although the corn DDGS and WM diets resulted in an increase (P < 0.001) in N consumption, N excretion was not affected (P > 0.10) compared with hens fed the control diet. The reduced-CP diets did not affect egg weight, feed consumption, or BW gain (P > 0.05); however, egg production, egg mass, feed utilization, N consumption, and N excretion were lower than that from the hens fed the normal-CP diets (P < 0.05). The results of this study show that the diets containing 10% corn DDGS, 7% WM, or 5% SH did not affect egg production or N excretion. However, the 1% lower CP diets caused a lower egg production and lower N excretion.

Responses of thyroid hormones of market-size broilers to thermoneutral constant and warm cyclic temperatures

This study characterizes the responses, particularly diurnal variations, of thyroid hormones (TH) [3,5,3'-triiodothyronine (T3), thyroxine (T4), and T3:T4 ratio (T3/T4)] of Arbor Acres broilers to constant thermoneutral (TN) or warm cyclic (WC) temperatures. There existed distinct circadian variations--2 peaks in TH under the TN and WC conditions. The 2 peaks of T3, T4, and T3/T4 of the broilers occurred, respectively, at 0 and 16 h, 8 and 16 h, and 0 and 12 h under the TN condition; but at 0 and 12 h, 0 and 8 h, and 4 and 12 h under the WC conditions. During a 5-d heat exposure (HE) to the WC regimens, T3 and T4 showed continual decrease. The daily mean of T3 declined significantly (P < 0.05) on the first day of HE, whereas significant decrease of T4 (P < 0.05) occurred on the second day of HE. There was no significant change in daily mean of T3/T4 during the same HE period. Hence, results of the study indicate that T3 provides a better heat stress indicator than T4. The nature of circadian variations in TH makes it necessary to collect blood samples more than once a day, e.g., 6 times at 0, 4, 8, 12, 16, and 20 h, to ensure full evaluation of hormonal responses of market-size broilers undergoing thermal challenges.

Nitrogen excretion and ammonia emissions from pigs fed modified diets

Two swine feeding trials were conducted (initial body weight = 47 +/- 2 and 41 +/- 3 kg for Trials 1 and 2, respectively) to evaluate reduced crude protein (CP) and yucca (Yucca schidigera Roezl ex Ortgies) extract-supplemented diets on NH3 emissions. In Trial 1, nine pigs were offered a corn-soybean meal diet (C, 174 g kg(-1) CP), a Lys-supplemented diet (L, 170 g kg(-1) CP), or a 145 g kg(-1) CP diet supplemented with Lys, Met, Thr, and Trp (LMTT). In Trial 2, nine pigs were fed diet L supplemented with 0, 62.5, or 125 mg of yucca extract per kg diet. Each feeding period consisted of a 4-d dietary adjustment followed by 72 h of continuous NH3 measurement. Urine and fecal samples were collected each period. Feeding the LMTT diet reduced (P < 0.05) average daily gain (ADG) and feed efficiency (G:F) compared to diet L. Fecal N concentration decreased with a reduction in dietary CP, but urinary ammonium increased from pigs fed diet LMTT (2.0 g kg(-1), wet basis) compared to those fed diet C (1.1 g kg(-1)) or L (1.0 g kg(-1)). When pigs were fed reduced CP diets NH3 emission rates decreased (2.46, 2.16, and 1.05 mg min(-1) for diets C, L, and LMTT). Yucca had no effect on feed intake, ADG, or G:F. Ammonium and N concentrations of manure and NH3 emission rates did not differ with yucca content. Caution must be executed to maintain animal performance when strategies are implemented to reduce NH3 emissions.

Immune evasion by melanoma and ovarian tumor cells through upregulation of the immunosuppressive molecule CD200

2545

Background: Immune escape by tumors can occur by multiple mechanisms, each a significant barrier to immunotherapy. Upregulation of the immunosuppressive molecule CD200 on chronic lymphocytic leukemia cells inhibits Th1 cytokine production required for an effective cytotoxic T cell response. CD200 expression on human tumor cells in animal models prevents human lymphocytes from rejecting the tumor; treatment with an antagonistic anti-CD200 antibody restored lymphocyte-mediated tumor growth inhibition. This study evaluated CD200 expression on other cancers, and its effect on immune response. Methods: CD200 levels in ovarian adenocarcinoma and metastatic melanoma samples were evaluated by RT-QPCR and immunohistochemistry. Cell-surface CD200 on melanoma and ovarian cancer cell lines was assessed by flow cytometry. The effect of CD200 on cytokine production in mixed lymphocyte reactions (MLR) was assessed by adding the cells to cultures containing human monocyte-derived dendritic cells and allogeneic T cells. Th1 and Th2 cytokines in culture supernatants were detected by ELISA. Results: RT-QPCR showed CD200 expression levels upregulated in serous ovarian adenocarcinoma compared to normal samples. In malignant melanoma, CD200 expression in jejunum metastases was significantly higher than in normal samples, and 2 of 6 lung metastases showed CD200 upregulation. IHC showed strong, membrane-associated CD200 staining on malignant cells of two melanoma patients. Three ovarian cancer patients showed varying levels of CD200 tumor staining; all showed strong stromal staining. CD200 was highly expressed on the cell surface of SK-MEL-24 and SK-MEL-28 melanoma and OV-CAR-3 ovarian cancer cell lines and moderately expressed on the melanoma cell line SK-MEL-5. Addition of these cell lines to MLRs downregulated the production of Th1 cytokines; addition of CD200-negative cell lines did not. Inclusion of an antagonistic anti-CD200 antibody during the culture restored Th1 cytokine responses. Conclusion: Melanoma and ovarian tumor cells can upregulate CD200, thereby potentially suppressing anti-tumor immune responses. Therapy with an antagonistic anti-CD200 antibody may permit an effective cytotoxic immune response against the tumor cells.

[Table: see text]

Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells

Proliferation of normal and malignant prostate epithelium is regulated by androgen stimulation via both the androgen receptor (AR)-positive stromal and epithelial cells. However, it is not known how AR expression is regulated in human prostate cells. We report that treatment of normal human prostate stromal cells (PrSCs) with type I IFN (alpha or beta), but not type II IFN (gamma), resulted in increased levels of AR protein. The maximal increase in AR protein levels was dependent on the dose and the duration of the IFN-alpha treatment. We found that the increase in AR protein levels was independent of de novo transcription and protein synthesis. Interestingly, the IFN-alpha treatment of PrSCs resulted in considerable nuclear accumulation of AR, stimulation of AR-mediated transcription of reporter genes, and retardation of cell proliferation. Furthermore, treatment of normal human prostate epithelial cells with IFNs (alpha, beta or gamma) also resulted in increased levels of AR protein. Together, our observations identify the androgen receptor as an IFN-regulated protein in normal human prostate stromal and epithelial cells and predict that IFN-induced levels of AR in prostate cells contribute to the regulation of androgen signaling.

Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease

BACKGROUND

Based on in vitro experiments using recombinant human thiopurine S-methyltransferase this enzyme is inhibited by sulfasalazine (sulphasalazine) and 5-aminosalicylate. Thus, during treatment with azathioprine or mercaptopurine, both metabolized by thiopurine S-methyltransferase, sulfasalazine or 5-aminosalicylate could modify the action of azathioprine/mercaptopurine.

AIMS

To examine whether this interaction is effective under ex vivo conditions.

METHODS

In 18 azathioprine-free patients and in 12 patients on azathioprine the inhibitory potential of sulfasalazine, 5-aminosalicylate and its metabolite (Ac-5-aminosalicylate) was assessed by ex vivo measurement of thiopurine S-methyltransferase in red blood cells.

RESULTS

According to concentration response curves mean IC50 values (microm) for sulfasalazine, 5-aminosalicylate and Ac-5-aminosalicylate have been calculated in three groups of azathioprine-free patients and variable basal levels of thiopurine S-methyltransferase activity (very high, normal and intermediate). In all three groups sulfasalazine was the strongest inhibitor (IC50: 9-17 microm) if compared with 5-aminosalicylate (129-236) and Ac-5-aminosalicylate (58-74). In patients on azathioprine similar IC50 values have been calculated.

CONCLUSIONS

Comparing human plasma concentrations of sulfasalazine (15-77 microm), 5-aminosalicylate (3-14 microm) and Ac-5-aminosalicylate (8-18 microm) with the IC50 values one can assume that only sulfasalazine would have the potential to inhibit thiopurine S-methyltransferase in vivo. However, the therapeutic impact should be proved by clinical studies.

Drinking water temperature effects on laying hens subjected to warm cyclic environments

Two experiments were conducted to evaluate the effects of drinking water temperature (Tw) on laying hens subjected to warm cyclic air temperature (Ta) conditions. Each experiment consisted of a 1-wk acclimation under thermoneutrality (TN) (Ta = Tw = 21 C), a 4-wk heat exposure or treatment period, and a 2-wk recovery under TN. Each experiment involved 24 individually caged hens at the initial age of 29 wk (Experiment 1) or 30 wk (Experiment 2). In Experiment 1, Tw of 18 or 27 C was provided to 12 birds per Tw regimen under a diurnal Ta of 27 to 35 C (daily mean of 31 C). In Experiment 2, Tw of 15, 19, 23, or 27 C was provided to six birds per Tw regimen under a diurnal Ta of 27 to 38 C (daily mean of 32.5 C). Experiment 1 showed that Tw of 18 C enhanced hourly and daily feed and water intake during the first 2 wk of heat exposure, as compared with Tw of 27 C. Experiment 2 showed that daily feed and water intake were greatest for hens in the 23 C Tw regimen and least for hens in the coolest or warmest Tw regimens. Reduction in daily feed intake with increase in daily mean Ta ranged from 2.0 to approximately 3.2 g/C-day (first week of heat exposure) to 1.1 to approximately 1.9 g/C-day (fourth week of heat exposure). Water to feed intake ratio was 1.8 to approximately 2.0 during acclimation and recovery, but increased to 3.0 to approximately 3.4 during heat exposure. Internal egg quality parameters were in general unaffected by Tw. The two warmer Tw regimens in Experiment 2 had less reduction in egg size than did the two cooler Tw. In both experiments, hens displayed anticipatory increase in feed and water intake 2 to 3 h prior to lights-off. However, the stimulus of lights-on did not elicit a strong return to feed and water consumption as typically seen in broilers. The results revealed the potential existence of an optimal Tw range (near 23 C) for heat-chal lenged laying hens. Larger-scale tests are warranted to further verify the findings.

Effects of noise on the off rate of Ca(2+) binding proteins in a coupled biochemical cell system

We investigated numerically the kinetic properties of calcium binding proteins by using a three-calcium store model and discussed the response of a two-way coupled biochemical cell system, whose subsystems were coupled via diffusion-like cytosolic calcium transfer through gap junctions, to the external stimulation. When we used noise to modulate the off rate of the Ca(2+) binding proteins in simulation, an SR-like phenomenon of synchronous oscillations is observed. In addition, the interaction involving noise, coupling and the dynamics of Ca(2+) binding proteins is discussed.

Interactions between HMG boxes

Many proteins consist of subdomains that can fold and function independently. We investigate here the interaction between the two high mobility group (HMG) box subdomains of the nuclear protein rHMG1. An HMG box is a conserved amino acid sequence of approximately 80 amino acids rich in basic, aromatic and proline side chains that is active in binding DNA in a sequence or structure-specific manner. In the case of HMG1, each box can bind structural DNA substrates including four-way junctions (4WJs) and branched or kinked DNA duplexes. Since proteins containing up to six HMG boxes are known, the question arises whether linking subdomains together influences the folding or function of individual boxes. In an effort to understand interactions between individual DNA-binding domains in HMG1, we created new fusion proteins: one is an inversion of the order of the AB di-domain in HMG1 (BA); in the second, we added a third A domain C-terminal to the AB di-domain (ABA). Pairs of boxes, AB or BA, behave similarly and are functionally active. By contrast, the ABA triple subdomain construct is partially unfolded and is less active than individual boxes or di-domains. Thus, long-range inter-domain effects can influence the activity of HMG boxes.